(CC) Chemours - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1638511089
CC EPS (Earnings per Share)
CC Revenue
CC: Refrigerants, Solvents, TiO2 Pigment, Resins, Additives, Films, Coatings
Chemours Co is a diversified chemicals company operating globally, with a presence in North America, Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company is organized into three main business segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, each offering a distinct portfolio of high-performance chemicals and materials.
The companys product offerings cater to a wide range of industries, including coatings, plastics, electronics, and energy. Its Thermal & Specialized Solutions segment is a leading provider of refrigerants, thermal management solutions, and specialty solvents, while the Titanium Technologies segment is a major supplier of TiO2 pigment used in various applications, including coatings, plastics, and packaging. The Advanced Performance Materials segment offers a diverse range of specialty materials, including membranes, resins, and coatings, used in high-tech industries such as consumer electronics, semiconductors, and medical devices.
Chemours Co has a strong brand portfolio, including well-known names such as Freon, Opteon, Ti-Pure, Teflon, Viton, Krytox, and Nafion. The company sells its products through a combination of direct and indirect channels, including a network of resellers, third-party sales agents, and distributors. With its global footprint and diversified product portfolio, Chemours Co is well-positioned to capitalize on growth opportunities in various end-markets.
Analyzing the companys
Based on the available data, a possible forecast for Chemours Co is that the stock may continue to experience short-term volatility, but its diversified product portfolio and global presence position it for long-term growth. As the company continues to navigate the challenges in its end-markets, its focus on innovation and high-performance materials is likely to drive future earnings growth. A potential trading strategy could involve monitoring the stocks price action and waiting for a breakout above its 50-day moving average of $11.21, with a target price of $14-$15, representing a 20-25% upside from current levels.
Additional Sources for CC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CC Stock Overview
Market Cap in USD | 1,669m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Diversified Chemicals |
IPO / Inception | 2015-07-01 |
CC Stock Ratings
Growth Rating | -28.5 |
Fundamental | -34.9 |
Dividend Rating | 43.6 |
Rel. Strength | -47.4 |
Analysts | 3.8 of 5 |
Fair Price Momentum | 10.26 USD |
Fair Price DCF | - |
CC Dividends
Dividend Yield 12m | 5.77% |
Yield on Cost 5y | 6.61% |
Annual Growth 5y | 0.00% |
Payout Consistency | 80.9% |
Payout Ratio | 82.2% |
CC Growth Ratios
Growth Correlation 3m | -46.1% |
Growth Correlation 12m | -82.2% |
Growth Correlation 5y | -22.3% |
CAGR 5y | -2.10% |
CAGR/Max DD 5y | -0.03 |
Sharpe Ratio 12m | -1.37 |
Alpha | -69.01 |
Beta | 2.007 |
Volatility | 50.40% |
Current Volume | 3581.2k |
Average Volume 20d | 3795.6k |
As of June 26, 2025, the stock is trading at USD 11.40 with a total of 3,581,238 shares traded.
Over the past week, the price has changed by +3.64%, over one month by +7.34%, over three months by -18.79% and over the past year by -47.50%.
Probably not. Based on ValueRay´s Fundamental Analyses, Chemours (NYSE:CC) is currently (June 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -34.93 and therefor a somewhat negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CC is around 10.26 USD . This means that CC is currently overvalued and has a potential downside of -10%.
Chemours has received a consensus analysts rating of 3.80. Therefor, it is recommend to hold CC.
- Strong Buy: 3
- Buy: 2
- Hold: 5
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, CC Chemours will be worth about 11.3 in June 2026. The stock is currently trading at 11.40. This means that the stock has a potential downside of -0.79%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 14.9 | 30.6% |
Analysts Target Price | 19.5 | 71.1% |
ValueRay Target Price | 11.3 | -0.8% |